422 related articles for article (PubMed ID: 11958881)
1. Erectile function after permanent prostate brachytherapy.
Merrick GS; Butler WM; Galbreath RW; Stipetich RL; Abel LJ; Lief JH
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):893-902. PubMed ID: 11958881
[TBL] [Abstract][Full Text] [Related]
2. Erectile function after prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Anderson RL; Kurko BS; Lief JH; Allen ZA
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):437-47. PubMed ID: 15890585
[TBL] [Abstract][Full Text] [Related]
3. Long-term potency preservation following brachytherapy for prostate cancer.
Snyder KM; Stock RG; Buckstein M; Stone NN
BJU Int; 2012 Jul; 110(2):221-5. PubMed ID: 22734475
[TBL] [Abstract][Full Text] [Related]
4. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction.
Merrick GS; Wallner K; Butler WM; Galbreath RW; Lief JH; Benson ML
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):597-604. PubMed ID: 11395225
[TBL] [Abstract][Full Text] [Related]
5. The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction.
Merrick GS; Butler WM; Wallner KE; Lief JH; Anderson RL; Smeiles BJ; Galbreath RW; Benson ML
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1055-62. PubMed ID: 12419431
[TBL] [Abstract][Full Text] [Related]
6. Erectile function durability following permanent prostate brachytherapy.
Taira AV; Merrick GS; Galbreath RW; Butler WM; Wallner KE; Kurko BS; Anderson R; Lief JH
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):639-48. PubMed ID: 19303721
[TBL] [Abstract][Full Text] [Related]
7. Rectal function following prostate brachytherapy.
Merrick GS; Butler WM; Dorsey AT; Galbreath RW; Blatt H; Lief JH
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):667-74. PubMed ID: 11020562
[TBL] [Abstract][Full Text] [Related]
8. Long-term potency after iodine-125 radiotherapy for prostate cancer and role of sildenafil citrate.
Raina R; Agarwal A; Goyal KK; Jackson C; Ulchaker J; Angermeier K; Klein E; Ciezki J; Zippe CD
Urology; 2003 Dec; 62(6):1103-8. PubMed ID: 14665364
[TBL] [Abstract][Full Text] [Related]
9. Permanent prostate brachytherapy-induced morbidity in patients with grade II and III obesity.
Merrick GS; Butler WM; Wallner K; Galbreath RW; Anderson RL; Kurko BS; Lief JH
Urology; 2002 Jul; 60(1):104-8. PubMed ID: 12100933
[TBL] [Abstract][Full Text] [Related]
10. A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction.
Merrick GS; Butler WM; Dorsey AT; Lief JH; Donzella JG
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1069-74. PubMed ID: 11072164
[TBL] [Abstract][Full Text] [Related]
11. Erectile function after brachytherapy with external beam radiation for prostate cancer.
Fujioka H; Ishimura T; Sakai Y; Fujii T; Jo Y; Takenaka A; Fujisawa M
Arch Androl; 2004; 50(4):295-301. PubMed ID: 15277008
[TBL] [Abstract][Full Text] [Related]
12. Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary results.
Wilder RB; Chou RH; Ryu JK; Stern RL; Wong MS; Ji M; Roach M; White RD
Am J Clin Oncol; 2000 Aug; 23(4):330-3. PubMed ID: 10955856
[TBL] [Abstract][Full Text] [Related]
13. Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer.
Stock RG; Stone NN; Iannuzzi C
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):267-72. PubMed ID: 8635932
[TBL] [Abstract][Full Text] [Related]
14. Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Lief JH; Allen Z; Adamovich E
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):32-43. PubMed ID: 15629591
[TBL] [Abstract][Full Text] [Related]
15. Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer.
Merrick GS; Butler WM; Galbreath RW; Lief JH
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):41-8. PubMed ID: 11516849
[TBL] [Abstract][Full Text] [Related]
16. Long-term urinary quality of life after permanent prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Lief JH
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):454-61. PubMed ID: 12738320
[TBL] [Abstract][Full Text] [Related]
17. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen spikes after permanent prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Anderson RL
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):450-6. PubMed ID: 12243821
[TBL] [Abstract][Full Text] [Related]
19. Short-term sexual function after prostate brachytherapy.
Merrick GS; Wallner K; Butler WM; Lief JH; Sutlief S
Int J Cancer; 2001 Oct; 96(5):313-9. PubMed ID: 11582584
[TBL] [Abstract][Full Text] [Related]
20. The effect on erectile function of 103palladium implantation for localized prostate cancer.
Ponholzer A; Oismüller R; Somay C; Büchler F; Maier U; Hawliczek R; Rauchenwald M; Madersbacher S
BJU Int; 2005 Apr; 95(6):847-50. PubMed ID: 15794796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
